Clozapine is an atypical antipsychotic that is used for treatment-resistant schizophrenia. The drug is subject to strict monitoring requirements because it is associated with serious side effects, such as neutropenia, agranulocytosis, seizures, myocarditis and cardiomyopathy. The incidence of neutropenia among clozapine-treated patients is 2% and agranulocytosis 0.8%.
Some 30–60% of patients...
To read the whole article click on the headline
To read the whole article click on the headline